Related references
Note: Only part of the references are listed.Expression of checkpoint molecules on myeloid-derived suppressor cells
Marlene Ballbach et al.
IMMUNOLOGY LETTERS (2017)
Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Lisa Derosa et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Mechanisms of T Cell Selection in the Thymus
Hiroyuki Takaba et al.
TRENDS IN IMMUNOLOGY (2017)
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
Yago Pico de Coana et al.
ONCOTARGET (2017)
Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
Paulo C. Rodriguez et al.
FRONTIERS IN IMMUNOLOGY (2017)
Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?
Monika Cervinkova et al.
ANTI-CANCER DRUGS (2017)
The multiple pathways to autoimmunity
Argyrios N. Theofilopoulos et al.
NATURE IMMUNOLOGY (2017)
Tumor promoting role of anti-tumor macrophages in tumor microenvironment
Kuntal Kanti Goswami et al.
CELLULAR IMMUNOLOGY (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Spontaneous regression of tumour and the role of microbial infection - possibilities for cancer treatment
Petra Kucerova et al.
ANTI-CANCER DRUGS (2016)
Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression
Krisztina Buzas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
Mouldy Sioud et al.
CASE REPORTS IN MEDICINE (2016)
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions
Laszlo G. Radvanyi
CANCER JOURNAL (2015)
Inhibitory receptors as targets for cancer immunotherapy
Meghan E. Turnis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
Yago Pico de Coana et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
Ester Simeone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Deconstructing the Peptide-MHC Specificity of T Cell Recognition
Michael E. Birnbaum et al.
CELL (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
Spontaneous regression of high grade primary gastric Lymphoma in an untreated viral hepatitis infection
Cristhiam M. Rojas-Hernandez et al.
LEUKEMIA & LYMPHOMA (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Mechanisms of neuroblastoma regression
Garrett M. Brodeur et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Engineering better immunotherapies via RNA interference
Mouldy Sioud
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8+ T-cell responses
Lazar Vujanovic et al.
ONCOIMMUNOLOGY (2014)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
Alexandr V. Bazhin et al.
ONCOIMMUNOLOGY (2013)
Galectin-1 and-3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
Anne Mobergslien et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
Lukas Baitsch et al.
PLOS ONE (2012)
Phenotype, Function, and Gene Expression Profiles of Programmed Death-1hi CD8 T Cells in Healthy Human Adults
Jaikumar Duraiswamy et al.
JOURNAL OF IMMUNOLOGY (2011)
Broad Cross-Reactive TCR Repertoires Recognizing Dissimilar Epstein-Barr and Influenza A Virus Epitopes
Shalyn C. Clute et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Hugo Mouquet et al.
NATURE (2010)
Mechanisms of costimulation
Arlene H. Sharpe
IMMUNOLOGICAL REVIEWS (2009)
Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+HCMV-specific cytotoxic T lymphocytes
Jong-Baeck Lim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Does our Current Understanding of Immune Tolerance, Autoimmunity, and Immunosuppressive Mechanisms Facilitate the Design of Efficient Cancer Vaccines?
M. Sioud
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Bacterial targeted tumour therapy-dawn of a new era
Ming Q. Wei et al.
CANCER LETTERS (2008)
Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells
Ian A. Parish et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
A mycoplasma peptide elicits heteroclitic CD4 T cell responses against tumor antigen MAGE-A6
Lazar Vujanovic et al.
CLINICAL CANCER RESEARCH (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Tolerogenic dendritic cells and regulatory T cells: A two-way relationship
Karsten Mahnke et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors
T Saito et al.
IMMUNOLOGICAL REVIEWS (2003)
Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
M Sioud et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Immunosuppression during acute Trypanosoma cruzi infection:: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells
O Goñi et al.
INTERNATIONAL IMMUNOLOGY (2002)
Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity
YJ Liu
CELL (2001)
Share Paper
